Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Change in Receivables: 2016-2024

Historic Change in Receivables for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to $31.8 million.

  • Organogenesis Holdings' Change in Receivables rose 1799.80% to $50.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $73.1 million, marking a year-over-year increase of 365.91%. This contributed to the annual value of $31.8 million for FY2024, which is 674.11% up from last year.
  • According to the latest figures from FY2024, Organogenesis Holdings' Change in Receivables is $31.8 million, which was up 674.11% from -$5.5 million recorded in FY2023.
  • In the past 5 years, Organogenesis Holdings' Change in Receivables ranged from a high of $31.8 million in FY2024 and a low of -$5.5 million during FY2023.
  • For the 3-year period, Organogenesis Holdings' Change in Receivables averaged around $11.7 million, with its median value being $8.8 million (2022).
  • Its Change in Receivables has fluctuated over the past 5 years, first plummeted by 163.16% in 2023, then surged by 674.11% in 2024.
  • Over the past 5 years, Organogenesis Holdings' Change in Receivables (Yearly) stood at $17.6 million in 2020, then skyrocketed by 63.11% to $28.7 million in 2021, then slumped by 69.39% to $8.8 million in 2022, then plummeted by 163.16% to -$5.5 million in 2023, then spiked by 674.11% to $31.8 million in 2024.